Abstract:Peptide (Gly-Pro-Leu-Gly-Ile-Ala-Gly-Gln), which can be specifically degraded by matrix metalloproteinases 2 (MMP-2), was conjugated into polylactic acid (PLA), constructing therefore a new type of MMP-responsive drug delivery system (DDS). Microparticles with core-shell structure were fabricated using coaxial electrospray. PEG was used as the shell and PLA-b-peptide-b-PLA as the core material. The water-soluble PEG shell was quickly removed from aqueous environment and the size of the microspheres was reduced from micron to nanometer scale. Eventually, MMP-2 responsive nanoparticles with a diameter of about 100 nm were obtained through coaxial electrospray-template removal method. MMP-2 response of the nanoparticles was investigated by the change of particle size and morphology with DLS and TEM. After coculturing with MMP-2 protease, the spherical skeleton of the nanoparticles was partly degraded. Meanwhile, part of the degraded particles got aggregated. This is because MMP-2 protease specifically cleave the peptide, resulting in the partly disassembly of the nanoparticles and random reassembling of PLA. Doxorubicin (DOX) was used as a model chemotherapeutic drug and loaded in the core of the nanoparticles. The drug loading content and entrapment efficiency of DOX were 0.326% and 75.3%, respectively. The in vitro release profile of DOX from the electrosprayed particles was studied. It was found that the encapsulated DOX was released from the nanoparticles, and the release was controlled by the stimulus of overexpressed MMP-2 protease, and the process lasted more than 20 days. The results show that coaxial electrospray-template removal method did not affect the matrix metalloproteinases response of the peptide, and thus the nanoparticles prepared have good MMP-2 responsiveness. Meanwhile, the size of the particles can be modulated by the coaxial electrospray-template removal method, and the nano-sized particles can be simply and effectively achieved. The study suggests that the coaxial electrospray-template removal method is a promising route to the preparation of stimuli-responsive drug delivery system.

Fabrication of MMP-2 Rresponsive Nanoparticles by Coaxial Electrospray-template Removal

The Exploration of Endocytic Mechanisms of PLA-PEG Nanoparticles Prepared by Coaxialtri-Capillary Electrospray-Template Removal Method.

Matrix Metalloproteinase-Sensitive Size-Shrinkable Nanoparticles for Deep Tumor Penetration and Ph Triggered Doxorubicin Release.

Matrix Metalloproteinases-2/9-sensitive Peptide-Conjugated Polymer Micelles for Site-Specific Release of Drugs and Enhancing Tumor Accumulation: Preparation and in Vitro and in Vivo Evaluation

Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

Building Stable Mmp2-Responsive Multifunctional Polymeric Micelles by an All-In-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery

Controlled release of doxorubicin from Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by coaxial electrospraying

De novo synthesis of pH-responsive, self-assembled, and targeted polypeptide nano-micelles for enhanced delivery of doxorubicin

Biodegradation and Toxicity of Protease/Redox/Ph Stimuli-Responsive Peglated Pmaa Nanohydrogels for Targeting Drug Delivery

Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery

MMP-2-Sensitive HA End-Conjugated Poly(amidoamine) Dendrimers Via Click Reaction to Enhance Drug Penetration into Solid Tumor.

Disulfide Cross-Linked Amphiphilic Copolymers Loading Doxorubicin for Controlled Drug Delivery

Synthesis and physicochemical properties of doxorubicin-loaded PEGA containing amphiphilic block polymeric micelles

MMPs-responsive silk spheres for controlled drug release within tumor microenvironment

Thermo and Ph Dual Responsive, Polymer Shell Coated, Magnetic Mesoporous Silica Nanoparticles for Controlled Drug Release

Bioresponsive Controlled Drug Release Based on Mesoporous Silica Nanoparticles Coated with Reductively Sheddable Polymer Shell

Construction of a New Dual-Responsive Nano-Drug Delivery System for Matrix Metalloproteinases and Adenosine Triphosphate in Ovarian Cancer Using Nanomicelles

Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect

Targeted Delivery and Release of Doxorubicin Using A Ph-Responsive and Self-Assembling Copolymer

Synthesis and pH-responsive self-assembly behavior of a fluorescent amphiphilic triblock copolymer mPEG-b-PCL-b-PDMAEMA-g-PC for the controlled intracellular delivery of doxorubicin